Intuitive Surgical, Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 5.71B | 6.22B | 7.12B | 8.35B | 10.06B | 20.5% | |
| Cost of Revenue | (1.75B) | (2.03B) | (2.39B) | (2.72B) | (3.42B) | 25.9% | |
Gross Profit | 3.96B | 4.20B | 4.73B | 5.63B | 6.64B | 17.9% | |
| Operating Expenses | |||||||
| Research & Development | (671.00M) | (879.00M) | (998.80M) | (1.15B) | (1.31B) | 14.5% | |
| Selling, General & Administrative | (1.47B) | (1.74B) | (1.96B) | (2.14B) | (2.38B) | 11.4% | |
| Depreciation & Amortization | (317.00M) | (365.80M) | (402.20M) | (462.00M) | (677.10M) | 46.6% | |
Operating Income (EBIT) | 1.82B | 1.58B | 1.77B | 2.35B | 2.95B | 25.4% | |
| Non-Operating Items | |||||||
| Interest Income | 69.30M | 29.70M | 192.10M | 324.90M | 365.90M | 12.6% | |
| Interest Expense | — | — | — | — | — | — | |
| Other Income/Expenses (Net) | 69.30M | 29.70M | 192.10M | 324.90M | 365.90M | 12.6% | |
Income Before Tax | 1.89B | 1.61B | 1.96B | 2.67B | 3.31B | 23.8% | |
| Income Tax Expense | (162.20M) | (262.40M) | (141.60M) | (336.30M) | (434.80M) | 29.3% | |
Net Income | 1.70B | 1.32B | 1.80B | 2.32B | 2.86B | 23.0% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $5 | $4 | $5 | $7 | $8 | 22.3% | |
| Weighted Avg Shares Outstanding | 356.10M | 355.70M | 351.20M | 355.20M | 356.90M | 0.5% | |
| Weighted Avg Shares Outstanding (Diluted) | 365.80M | 362.00M | 357.40M | 362.00M | 362.70M | 0.2% | |
EBITDA | 2.21B | 1.97B | 2.36B | 3.14B | 3.99B | 27.2% |
Explore ISRG
ISRG in the Healthcare
Large Cap